Mahendran M - Search Results

1

Correction: Risk Factors for Empiric Treatment Failure in US Female Outpatients with Uncomplicated Urinary Tract Infection: an Observational Study.

Fromer DL, Luck ME, Cheng WY, Mahendran M, da Costa WL, Pinaire M, Duh MS, Preib MT, Ellis JJ. Fromer DL, et al. Among authors: mahendran m. J Gen Intern Med. 2024 Dec 16. doi: 10.1007/s11606-024-09265-w. Online ahead of print. J Gen Intern Med. 2024. PMID: 39681773 No abstract available.

2

Risk Factors for Empiric Treatment Failure in US Female Outpatients with Uncomplicated Urinary Tract Infection: an Observational Study.

Fromer DL, Luck ME, Cheng WY, Mahendran M, da Costa WL, Pinaire M, Duh MS, Preib MT, Ellis JJ. Fromer DL, et al. Among authors: mahendran m. J Gen Intern Med. 2024 Oct 2. doi: 10.1007/s11606-024-09029-6. Online ahead of print. J Gen Intern Med. 2024. PMID: 39356448

3

Likelihood of Antimicrobial Resistance in Urinary E. coli Isolates Among US Female Patients with Recurrent Versus Non-Recurrent uUTI.

Fromer DL, Cheng WY, Gao C, Mahendran M, Hilts A, Duh MS, Joshi AV, Mulgirigama A, Mitrani-Gold FS. Fromer DL, et al. Among authors: mahendran m. Urology. 2024 Aug;190:1-10. doi: 10.1016/j.urology.2024.02.047. Epub 2024 Mar 11. Urology. 2024. PMID: 38467284 Free article.

4

Development of Predictive Models to Inform a Novel Risk Categorization Framework for Antibiotic Resistance in Escherichia coli-Caused Uncomplicated Urinary Tract Infection.

Shields RK, Cheng WY, Kponee-Shovein K, Indacochea D, Gao C, Kuwer F, Joshi AV, Mitrani-Gold FS, Schwab P, Ferrinho D, Mahendran M, Pinheiro L, Royer J, Preib MT, Han J, Colgan R. Shields RK, et al. Among authors: mahendran m. Clin Infect Dis. 2024 Aug 16;79(2):295-304. doi: 10.1093/cid/ciae171. Clin Infect Dis. 2024. PMID: 38573310 Free PMC article.

5

Time-to-first exacerbation, adherence, and medical costs among US patients receiving umeclidinium/vilanterol or tiotropium as initial maintenance therapy for chronic obstructive pulmonary disease: a retrospective cohort study.

Slade D, Ray R, Moretz C, Germain G, Laliberté F, Shen Q, Duh MS, Mahendran M, Hahn B. Slade D, et al. Among authors: mahendran m. BMC Pulm Med. 2021 Jul 31;21(1):253. doi: 10.1186/s12890-021-01612-5. BMC Pulm Med. 2021. PMID: 34332555 Free PMC article.

6

Dosing Patterns of Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Ravulizumab in the United States: A Retrospective Claims-Based Analysis.

Cheng WY, Fishman J, Yenikomshian M, Mahendran M, Kunzweiler C, Vu JD, Duh MS. Cheng WY, et al. Among authors: mahendran m. Adv Ther. 2024 Jan;41(1):413-430. doi: 10.1007/s12325-023-02725-5. Epub 2023 Nov 24. Adv Ther. 2024. PMID: 37999832 Free PMC article.

7

Real-World Healthcare Resource Utilization, Healthcare Costs, and Injurious Falls Among Elderly Patients with Geographic Atrophy.

Sarda SP, Germain G, Mahendran M, Klimek J, Cheng WY, Luo R, Duh MS. Sarda SP, et al. Among authors: mahendran m. Clin Ophthalmol. 2024 Nov 9;18:3215-3226. doi: 10.2147/OPTH.S475331. eCollection 2024. Clin Ophthalmol. 2024. PMID: 39539801 Free PMC article.

8

Symptom control in patients with asthma using inhaled corticosteroids/long-acting β₂-agonists (fluticasone furoate/vilanterol or budesonide/formoterol) in the US: a retrospective matched cohort study.

Averell CM, Laliberté F, Germain G, Duh MS, Lima R, Mahendran M, Slade DJ. Averell CM, et al. Among authors: mahendran m. J Asthma. 2022 Sep;59(9):1805-1818. doi: 10.1080/02770903.2021.1963767. Epub 2021 Aug 25. J Asthma. 2022. PMID: 34375568 Free article.

9

Real-World Study of Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol on Asthma Control in the US.

Bogart M, Germain G, Laliberté F, Mahendran M, Duh MS, DiRocco K, Noorduyn SG, Paczkowski R, Balkissoon R. Bogart M, et al. Among authors: mahendran m. J Asthma Allergy. 2023 Dec 1;16:1309-1322. doi: 10.2147/JAA.S424055. eCollection 2023. J Asthma Allergy. 2023. PMID: 38058516 Free PMC article.

10

Real-World Healthcare Resource Utilization (HRU) and Costs of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Receiving Eculizumab in a US Population.

Cheng WY, Sarda SP, Mody-Patel N, Krishnan S, Yenikomshian M, Mahendran M, Lejeune D, Yu LH, Duh MS. Cheng WY, et al. Among authors: mahendran m. Adv Ther. 2021 Aug;38(8):4461-4479. doi: 10.1007/s12325-021-01825-4. Epub 2021 Jul 17. Adv Ther. 2021. PMID: 34275086 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters